Open AccessChimeric Antigen Receptors Drive Best Responses in ALL in First Relapse
Author(s) -
Mark L. Fuerst
Publication year - 2022
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000832044.26488.6e
Subject(s) - chimeric antigen receptor , medicine , salvage therapy , oncology , disease , car t cell therapy , hematology , refractory (planetary science) , lymphoblastic leukemia , cancer , chemotherapy , leukemia , immunotherapy , biology , astrobiology